Investigators in Israel and Italy have developed a model of the blood-brain barrier, studies of which may lead to prevention of meningitis in newborns.
Dr. Dominik Kugelstadt joins as Head of Clinical and Commercial Manufacturing, Laupheim – Biotech Investments
EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma SE : Dr. Dominik Kugelstadt joins as Head of Clinical and Commercial Manufacturing, Laupheim 12.07.2023